Provention Bio, Inc is a biotechnology business based in the US. Provention Bio shares (PRVB) are listed on the NASDAQ and all prices are listed in US Dollars. Provention Bio employs 59 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Provention Bio
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PRVB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Provention Bio stock price (NASDAQ: PRVB)Use our graph to track the performance of PRVB stocks over time.
Provention Bio shares at a glance
|Latest market close||$7.61|
|52-week range||$5.72 - $19.19|
|50-day moving average||$7.34|
|200-day moving average||$10.09|
|Wall St. target price||$17.93|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.94|
Buy Provention Bio shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Provention Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Provention Bio price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||-8.31%|
|3 months (2021-04-30)||5.84%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Provention Bio financials
|Gross profit TTM||$0|
|Return on assets TTM||-51.08%|
|Return on equity TTM||-92.86%|
|Market capitalisation||$384.7 million|
TTM: trailing 12 months
Shorting Provention Bio shares
There are currently 5.2 million Provention Bio shares held short by investors – that's known as Provention Bio's "short interest". This figure is 5.2% down from 5.5 million last month.
There are a few different ways that this level of interest in shorting Provention Bio shares can be evaluated.
Provention Bio's "short interest ratio" (SIR)
Provention Bio's "short interest ratio" (SIR) is the quantity of Provention Bio shares currently shorted divided by the average quantity of Provention Bio shares traded daily (recently around 2.0 million). Provention Bio's SIR currently stands at 2.55. In other words for every 100,000 Provention Bio shares traded daily on the market, roughly 2550 shares are currently held short.
However Provention Bio's short interest can also be evaluated against the total number of Provention Bio shares, or, against the total number of tradable Provention Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Provention Bio's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Provention Bio shares in existence, roughly 80 shares are currently held short) or 0.1221% of the tradable shares (for every 100,000 tradable Provention Bio shares, roughly 122 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Provention Bio.
Find out more about how you can short Provention Bio stock.
Provention Bio share dividends
We're not expecting Provention Bio to pay a dividend over the next 12 months.
Provention Bio share price volatility
Over the last 12 months, Provention Bio's shares have ranged in value from as little as $5.72 up to $19.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Provention Bio's is 3.0426. This would suggest that Provention Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Provention Bio overview
Provention Bio, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-6527, an oral CSF-1R inhibitor, which has completed Phase IIa clinical trial for the treatment of Crohn's disease; PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co. , Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China.
Stocks similar to Provention Bio
Provention Bio in the news
Provention Bio: Blood (Glucose) In The Streets
Provention Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
Provention Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
Frequently asked questionsWhat percentage of Provention Bio is owned by insiders or institutions?
Currently 19.018% of Provention Bio shares are held by insiders and 47.655% by institutions. How many people work for Provention Bio?
Latest data suggests 59 work at Provention Bio. When does the fiscal year end for Provention Bio?
Provention Bio's fiscal year ends in December. Where is Provention Bio based?
Provention Bio's address is: 55 Broad Street, Red Bank, NJ, United States, 07701 What is Provention Bio's ISIN number?
Provention Bio's international securities identification number is: US74374N1028 What is Provention Bio's CUSIP number?
Provention Bio's Committee on Uniform Securities Identification Procedures number is: 74374N102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert